CDSCO monthly lab alert
CDSCO NSQ alert, January 2026: 218 drug batches flagged
By Blacklisted editorial team· Published 20 Feb 2026· Updated 20 Sep 2026· Source: CDSCO NSQ portal
In its January 2026 alert, the Central Drugs Standard Control Organisation listed 218 drug batches that failed quality tests, 68 at central laboratories and 150 at state drug-testing laboratories, from 172 manufacturers across 147 products. The most common failure was assay, and the most-represented manufacturing state was Himachal Pradesh. Products flagged include Buprenorphine Injection IP 2ml, Ambroxol Hydrochloride, Terbutaline Sulphate and Guaiphenesin Syrup, Rabeprazole Sodium Injection IP.
218
Batches flagged
68 / 150
Central / state labs
Assay
Top reason
172
Manufacturers
Batches per month, last 12 alerts
Feb 2025Jan 2026 · 218
Full list of NSQ batches, January 2026
Download CSV| Product | Batch | Manufacturer | Reason declared NSQ | Tested by |
|---|---|---|---|---|
| Zinc Sulphate Dispersable tablets I.P 20mg | 7066Mfg 2024-04 · Exp 2026-03 | Health Life Pharma | The sample does not conform to I.P limit� with respect to� Disintegration TestDisintegration | BDCL, PatnaState lab |
| Zinc Sulphate Dispersable tablets I.P 20mg | 25607Mfg 2024-03 · Exp 2026-02 | Health Life Pharma | The sample does not conform to I.P limit� with respect to� Disintegration TestDisintegration | BDCL, PatnaState lab |
| White Tone Face Powder | CW3858Mfg 2025-06 · Exp 2027-05 | VINI Cosmetics Pvt. LtdGujarat | Test for Heavy Metals(Lead)Other | DTL, Bengaluru, KarnatakaState lab |
| Tricholine Citrate and Sorbitol Syrup | 7917Mfg 2025-09 · Exp 2027-08 | Sabui Medical Stores(MFG.)West Bengal | The sample does not conform to the Manufacturer's Specification with respect to the Assay of Sorbitol Solution.Assay | CDL, KolkataCDSCO lab |
| Terbutaline, Ambroxol Hydrochloride, Guaiphenesin & Menthol Syrup | L - 25055Mfg 2025-09 · Exp 2027-08 | H. L. Healthcare Pvt. LtdHimachal Pradesh | The sample does not conform to claim as per Patent and Proprietary in respect to the Assay of Ambroxol Hydrochloride and MentholAssay | RDTL, ChandigarhCDSCO lab |
| Terbutaline Sulphate, Guaiphenesin, Ambroxol Hydrochloride and Menthol Syrup | BKS24014CMfg 2024-11 · Exp 2026-10 | Cachet Pharmaceuticals Pvt. LtdHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Terbutaline Sulphate, Guaiphenesin & Ambroxol Hcl Syrup | HTD-24103Mfg 2024-04 · Exp 2026-03 | American Pharma and Sciences | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Terbutaline Sulphate, Bromhexine Hydrochloride, Guiaphenesin & Menthol Syrup | EM1LF002Mfg 2025-04 · Exp 2027-03 | Unicure India LtdUttarakhand | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Terbutaline Sulphate, Bromhexine Hydrochloride, Guaiphenesin & Menthol Syrup | LXB-003Mfg 2025-08 · Exp 2027-07 | Bindlysh Biotec LtdDelhi | The sample does not conform to claim as per Patent and Proprietary in respect to the Assay of Bromhexine HydrochlorideAssay | RDTL, ChandigarhCDSCO lab |
| Terbutaline Sulphate, Bromhexine Hcl, Guaiphenesin Syrup | D240694Mfg 2024-09 · Exp 2026-08 | Dr.Reddy's Laboratories LimitedHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Terbutaline Sulphate, Bromhexine HCl, Guaiphenesin & Menthol Syrup, | LPS-2510209Mfg 2025-10 · Exp 2027-09 | Lapan Healthcare Pvt. LtdHaryana | The sample does not conform to claim as per Patent and Proprietary in respect to the Assay of Terbutaline Sulphate, Bromhexine HydrochlorideAssay | RDTL, ChandigarhCDSCO lab |
| Terbutaline Sulphate, Ambroxol, Hydrochloriode. Guaiphenesin & Menthol Syrup | DL505018Mfg 2025-05 · Exp 2027-04 | Renowed Life SciencesUttarakhand | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Terbutaline Sulphate, Ambroxol Hydrochloride and Guaiphenesin Syrup | AKL26Mfg 2025-10 · Exp 2027-09 | Aucklane Life Sciences Pvt. LtdPuducherry | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Teneligliptin & Metformin Hydrochloride Extended-release Tablets 20mg and 500mg | T-2406105Mfg 2024-06 · Exp 2026-05 | Rivpra Formulation Pvt. LtdUttarakhand | The sample received does not conform to I.P. 2022 with respect to the test of Dissolution (Teneligliptin) and Assay /Content of TeneligliptinAssay | CDTL, MumbaiCDSCO lab |
| Teneligliptin & Metformin Hydrochloride Extended-release Tablets 20mg and 500mg | T-2509069Mfg 2025-09 · Exp 2027-08 | Rivpra Formulation Pvt. LtdUttarakhand | The sample received does not conform to I.P. 2022 with respect to the test for Dissolution (Teneligliptin)Dissolution | CDTL, MumbaiCDSCO lab |
| Telmisartan Tablets IP 40mg | BPLT-25010Mfg 2025-01 · Exp 2026-12 | Bennet Pharmaceuticals LimitedHimachal Pradesh | sample fails the 'Descriptive Part' as per IPOther | DTL ThiruvananthapuramState lab |
| Telmisartan Tablets IP 40mg | STS-126Mfg 2025-06 · Exp 2027-05 | Marc Lifesciences SikkimSikkim | DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab |
| Telmisartan Tablets IP 40 mg | MVT-534Mfg 2024-08 · Exp 2026-07 | Bonn Schtering Bio SciencesPuducherry | Test for DissolutionDissolution | RDTL, Bellary, KarnatakaState lab |
| Telmisartan Tablets IP 40 mg | STS-117Mfg 2025-05 · Exp 2027-04 | Marc Lifesciences SikkimSikkim | DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab |
| Telmisartan Tab.IP 40mg | T3385Mfg 2024-02 · Exp 2026-01 | Titanes Pharma Vill. Bathu | The sample does not conform to I.P. The sample declared as Not of Standard Quality in respect of the Test Assay performed.Assay | West BengalState lab |
| Telmisartan & Amlodipine Tablets IP | ZTF-058AMfg 2025-06 · Exp 2027-05 | Zoic Biotech Pvt. LtdPunjab | Test for DissolutionDissolution | DTL, Bengaluru, KarnatakaState lab |
| Suction Catheter | SUBLE01Mfg 2025-05 · Exp 2028-04 | Morrisons Lifecare Pvt LtdTamil Nadu | The sample does not conforms to claim as per IS 8836:2019 with respect to test of 1st eye distance from tip.Other | RDTL, ChandigarhCDSCO lab |
| Sodium Chloride and Dextrose Injection IP(0.9% W/V and 5% W/v) | (N)251074Mfg 2025-04 · Exp 2027-03 | Klokter Lifesciences Pvt.Ltd Samora | The sample does not conform to I.P w.r.t Sterility TestSterility | DTL, Dalgate Srinagar Kashmir ( J and K)State lab |
| Sodium Bicarbonate Injection I.P | 524Mfg 2025-08 · Exp 2027-07 | Carewin Pharmaceuticals (Guj) Pvt. LtdGujarat | Description and Test for Particulate matterDescription | DTL, Bengaluru, KarnatakaState lab |
| Shringar Mehandi Cone | 1025SHMfg 2025-10 · Exp 2026-03 | Sankhla Mehandi Udyog | The sample of cosmetics- (C) Does not conform to the claims made on the label as to the nature and quality of the cosmetic with respect to Lawsone content.Labelling | DTL JaipurState lab |
| Salbutamol Syrup IP | SVK 24049Mfg 2024-11 · Exp 2026-10 | Labinduss LtdKerala | sample fails the test pH as per IP .pH | RDTL ErnakulamState lab |
| SANKHA VATI 5g (Ayurvedic) | KT-098Mfg 2025-11 · Exp 2028-10 | Karnani Pharmaceuticals (P) Ltd | The sample does not conform to Standard Quality in respect of the tests for Total Ash value performed.Other | SDTL Govt. of Tripura, AgartalaState lab |
| Rabeprazole Sodium Injection IP | MD25C07Mfg 2025-03 · Exp 2027-02 | Martin & Brown Bio-Sciences Pvt. LtdHimachal Pradesh | The sample does not conform to I.P with respect to the Tests of pH, Clarity of Solution, Particulate matter, Related Substances, Assay of Rabeprazole Sodium and Description.Assay | CDL, KolkataCDSCO lab |
| Rabeprazole Sodium Injection IP | MD24A09Mfg 2024-01 · Exp 2025-12 | Martin & Brown Bio-Sciences Pvt. LtdHimachal Pradesh | The sample does not conform to I.P. with respect to the tests of Clarity of solution, Particulate matter, pH, Related substances, Assay of Rabeprazole Sodium and Description.Assay | CDL, KolkataCDSCO lab |
| Rabeprazole Sodium Injection IP | MD25B16Mfg 2025-02 · Exp 2027-01 | Martin &Brown Bio-Sciences Pvt. LtdHimachal Pradesh | The sample does not conform to I.P with respect to the Tests for Clarity of Solution and Particulate matter.Particulate matter | CDL, KolkataCDSCO lab |
| Rabeprazole Sodium Gastro-resistant and Domperidone Prolonged-release Capsules | BHC-25070175Mfg 2025-07 · Exp 2026-12 | BON-HEUR PharmaceuticalsUttarakhand | The sample does not conform to the claim with respect to Assay of Rabeprazole Sodium.Assay | DTL JaipurState lab |
| Rabeprazole Sodium Gastro-Resistant Tablets IP 20 mg | TG25015EMfg 2025-08 · Exp 2027-07 | Curehealth Phaemaceuticals Pvt. LtdHimachal Pradesh | DescriptionDescription | RDTL, Bellary, KarnatakaState lab |
| Rabeprazole (EC) & Domperidone (SR) Capsules | NBC-01225Mfg 2025-05 · Exp 2027-04 | Neubin Life Sciences Pvt. LtdUttarakhand | The sample does not conform to the claim with respect to Assay of Rabeprazole Sodium.Assay | DTL JaipurState lab |
| ROSE-4 DSR | C2269Mfg 2025-01 · Exp 2026-12 | Supercure Biotech Pvt. Ltd. Plot No. 99/4/1Haryana | content of RabeprazoleOther | Uttar PradeshState lab |
| Pushp Henna Red Fast Colour Red Strong & Long Lasting | FH-1293Mfg 2025-10 · Exp 2027-09 | Pushp Henna Pvt. Ltd | The sample of cosmetics- (C) does not conform to the claims made on the label as to the nature and quality of the cosmetic with respect to protocol of test applied. The Sample does not confirm to IS 17318 : 2020 as it does not show the Lawsone content NiL.Labelling | DTL JaipurState lab |
| Pregabalin & Nortriptyline Tablets | PT-042515Mfg 2025-04 · Exp 2027-03 | Primus PharmaceuticalsHimachal Pradesh | The sample does not conform to the claim with respect to Assay in Nortriptyline.Assay | DTL JaipurState lab |
| Prednisolone Tablets IP 5mg | ATS-25001Mfg 2025-05 · Exp 2028-04 | Okvik Pharma Pvt. Ltd. 1913-KHaryana | AssayAssay | Uttar PradeshState lab |
| Povidone-Iodine Ointment USP | OG5019AMfg 2025-07 · Exp 2027-06 | Navkar LifesciencesHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Povidone Iodine Solution IP | GMW0121Mfg 2024-09 · Exp 2026-08 | Microwin Labs Pvt Ltd Plot No. 363Punjab | sample does not meets the Specifications wrt. Assay of Available lodine as per IP. 2022.Assay | DCL, TelanganaState lab |
| Piroxicam & Paracetamol Injection [POK-P] (FOR VETRINARY USE ONLY) | PK-2535Mfg 2025-06 · Exp 2027-05 | Sunvet Pharma Pvt. LtdHimachal Pradesh | Test for Sterility and DescriptionDescription | DTL, Bengaluru, KarnatakaState lab |
| Phenytoin Tablets IP 100 mg | T-5616Mfg 2025-04 · Exp 2027-03 | Jackson Laboratories Pvt. LtdPunjab | The sample fails in the Test for Description of Tablets.Description | MDTL Kathua, Jammu and KashmirState lab |
| Phenylephrine Hydrochloride, Dextromethorphan Hydrobromide, Chlorpheniramine Maleate & Guaiphenesin Syrup | IDS-1792Mfg 2025-04 · Exp 2027-03 | Indian Drug VisionUttarakhand | The sample does not conform to claim as per Schedule V, Drugs & Cosmetics Act in respect to the Assay of Phenylephrine HydrochlorideAssay | CDL, KolkataCDSCO lab |
| Phenylephrine Hcl & Chlorpheniramine Maleate, Paracetamol Oral Suspension | BHCI273Mfg 2025-03 · Exp 2028-02 | Baseman Healthcare Inc | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Paracetamol, Phenylphrine & Chlorpheniramine Maleate Suspension | 101Mfg 2025-10 · Exp 2027-09 | P & B Pharmaceuticals Pvt. LtdGujarat | The sample received does not conform to I.P. 2022 with respect to the test for Microbiological test.Other | CDTL, MumbaiCDSCO lab |
| Paracetamol, Phenylephrine Hydrochloride & Chlorpheniramine Maleate Suspension | ASL24288Mfg 2024-12 · Exp 2026-11 | AASSK Pharmaceuticals Pvt. LtdTamil Nadu | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Paracetamol, Phenylepherine HCL & Chlorpheniramine Maleate Suspension | TLLK-703Mfg 2025-11 · Exp 2027-10 | Taksa LifesciencePunjab | The sample does not conform to manufacturers specification with respect to the tests for Assay.Assay | CDTL, HyderabadCDSCO lab |
| Paracetamol, Chlorpheniramine Maleate, Phenylephrine Hydrochloride, Sodium Citrate & Menthol Suspension | 24L041Mfg 2024-05 · Exp 2026-04 | Acumen Pharmaceuticals Pvt. Ltd. -Unit-IIPuducherry | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Paracetamol Tablets IP 650mg | PCT25094Mfg 2025-05 · Exp 2027-04 | Vivek Pharmachem (India) LtdRajasthan | The sample has been declared as Not of Standard Quality as it does not conform to IP standards with respect to Test for Dissolution only.Dissolution | KarnatakaState lab |
| Paracetamol Tablets IP 500mg | PCT1211Mfg 2024-08 · Exp 2026-07 | Unicure India Ltd.C-21Uttar Pradesh | The sample does not confirm to IP2022 requirement withespect to Dissolution TestDissolution | DTL,Dalgate Srinagar Kashmir( J and K)State lab |
| Paracetamol Tablets IP 500mg | PAK-632Mfg 2024-01 · Exp 2026-12 | Healer's LabHimachal Pradesh | sample fails the test "Dissolution" as per IPDissolution | DTL ThrissurState lab |
| Paracetamol Tablets IP 500 mg | 4D189Mfg 2025-02 · Exp 2027-01 | Elegant Drugs Pvt. LtdKarnataka | Test for DissolutionDissolution | RDTL, Bellary, KarnatakaState lab |
| Paracetamol Tablets IP 500 mg | PYA24001Mfg 2024-06 · Exp 2026-05 | Danish Health Care (P) Ltd | DescriptionDescription | DTL, Bengaluru, KarnatakaState lab |
| Paracetamol Tablets IP | GTF0653Mfg 2025-03 · Exp 2027-02 | Digital VisionHimachal Pradesh | The sample does not conform to the IP with respect to Assay.Assay | DTL JaipurState lab |
| Paracetamol Tablets I.P. 650 mg | 2309026Mfg 2023-09 · Exp 2026-08 | Aban PharmaceuticalsKerala | The sample does not conform to standard quality in respect of the test for Dissolution performed.Dissolution | SDTL Govt. of Tripura, AgartalaState lab |
| Paracetamol Pediatric Oral Suspension IP | L4H088Mfg 2024-08 · Exp 2026-07 | Smayan Healthcare Pvt ltd Plot No. 26-27Himachal Pradesh | Assay for paracetamol does not comply as per IP 2022.Assay | DCL, TelanganaState lab |
| Paracetamol DispersibleTablets BP 500mg | HPJ405Mfg 2024-09 · Exp 2027-08 | Med Manor Organics Pvt.Ltd Uint IIUttarakhand | The sample does not conform to I.P w.r.t the Disintegration test and finess of DispersionDisintegration | DTL, Dalgate Srinagar Kashmir ( J and K)State lab |
| Paracetamol | TF3059AMfg 2023-06 · Exp 2026-05 | Navkar LifesciencesHimachal Pradesh | Dissolution TestDissolution | SDT&RL, BhubaneswarState lab |
| Paracad-650 | GAB2724Mfg 2024-01 · Exp 2026-12 | Aagya Biotech Pvt. Ltd. 1.5 kmUttarakhand | The sample fails in the Test for Description of Tablets.Description | MDTL Kathua, Jammu and KashmirState lab |
| Pantoprazole for Injection IP 40 mg | 25GF05AMfg 2025-06 · Exp 2027-05 | MMG HealthcareHimachal Pradesh | The sample does not conform to I.P. with respect to test for Particulate matter, and Clarity of solutionParticulate matter | CDL, KolkataCDSCO lab |
| Pantoprazole Tablets IP | PPC-5021Mfg 2025-02 · Exp 2027-01 | Spinka Pharma 6-18/4Telangana | Dissolution And Misbranded DrugDissolution | DCL, TelanganaState lab |
| Pantoprazole Tablets IP | T 3006Mfg 2025-05 · Exp 2027-04 | Hamax PharmaceuticalsGujarat | DescriptionDescription | RDTL, Bellary, KarnatakaState lab |
| Pantoprazole Sodium Gastro-resistant & Domperidone Prolonged Release Capsule IP | C-1594Mfg 2024-02 · Exp 2026-01 | Supercure Biotech Pvt. Ltd. Plot No. 99/4/1Haryana | Assay of DomperidoneAssay | Uttar PradeshState lab |
| Pantoprazole Gastro resistant Tablets IP | GT400378Mfg 2024-06 · Exp 2026-05 | Gnosis Pharmaceuticals Pvt. LtdHimachal Pradesh | The sample does not conform to standard quality in respect of the test for Description and Dissolution in Buffer medium performed.Dissolution | SDTL Govt. of Tripura, AgartalaState lab |
| Pantoprazole Gastro Resistant Tablets IP | TG25-1814AMfg 2025-10 · Exp 2027-09 | Athens Life SciencesHimachal Pradesh | Failed Disintegration and Uniformity of weightDisintegration | DTL, PuducherryState lab |
| Pantoprazole | 2425105Mfg 2024-06 · Exp 2026-05 | Ronak Life Care Private Limited. RS No 41(Part)Gujarat | Dissolution TestDissolution | SDT&RL, BhubaneswarState lab |
| Paediatric Co-Trimoxazole Oral Suspension BP | ATS25009Mfg 2025-06 · Exp 2028-05 | Unique Pharmaceutical Labs. (A Division of J. B. Chemicals & Pharmaceuticals Ltd.)Gujarat | The sample does not conform to B.P with respect to the Assay of SulphamethoxazoleAssay | CDTL, IndoreCDSCO lab |
| Oxytocin Injection (Vet.) | 04Mfg 2024-12 · Exp 2027-11 | Super Vaishali LaboratoriesBihar | The sample does not conform to claim as per Schedule V, Drugs & Cosmetics Act 1940 with respect to test for Particulate matter and Description.Description | CDL, KolkataCDSCO lab |
| Ondansetron Injection IP | LA24174BMfg 2025-02 · Exp 2027-01 | Symbiosis Pharmaceuticals Pvt.LtdHimachal Pradesh | The sample does not comply as per I.P. 2022 with respect to the test for Sterility and BETSterility | RDTL,GuwahatiCDSCO lab |
| Omeprazole Gastro-resistant Capsules IP 20 mg | JDC-1592Mfg 2025-04 · Exp 2027-03 | Jpee DrugsUttarakhand | Test for DissolutionDissolution | RDTL, Hubli, KarnatakaState lab |
| Ofloxacin, Metronidazole & Simethicone Suspension | ZRSL - 1533Mfg 2025-06 · Exp 2027-05 | ZRS Pharmaceuticals India Pvt.LtdHimachal Pradesh | The sample does not conform to claim as per Patent and Proprietary in respect to the Assay of Ofloxacin.Assay | RDTL, ChandigarhCDSCO lab |
| Ofloxacin And Ornidazole Tablets IP | 51Mfg 2024-11 · Exp 2026-10 | Square PharmaceuticalsWest Bengal | The sample declared as Misbranded Drug as per Sec 17(a) and 17(b) of Drugs and Cosmetics Act 1940 as it is not labelled in the prescribed manner. The sample declared as Not of Standard Quality in respect of the Test Assay performed.Assay | West BengalState lab |
| Ofloxacin & Ornidazole Tablets IP | OBT-2972Mfg 2024-04 · Exp 2026-03 | Park PharmaceuticalsHimachal Pradesh | Dissolution TestDissolution | SDT&RL, BhubaneswarState lab |
| Nitrazepam Tablets IP 5 mg | 208Mfg 2025-01 · Exp 2027-12 | Elite Pharma Pvt. LtdGujarat | Test for Dissolution onlyDissolution | RDTL, Bellary, KarnatakaState lab |
| Nimesulied & Paracetamol Tablets | 24T021Mfg 2024-04 · Exp 2027-03 | Medico LabsGujarat | Test for Disintegration onlyDisintegration | RDTL, Hubli, KarnatakaState lab |
| Multivitamin Tablets N.F.I. | 23448Mfg 2024-11 · Exp 2026-10 | Healthy Life Pharma Pvt. LtdMaharashtra | The sample does not confirm to the claim with respect to Assay of vitamin D3 (Nil).Assay | DTL JaipurState lab |
| Metronidazole Tablets I.P. 400 mg. | MT-24027Mfg 2024-05 · Exp 2026-04 | Medivs Biosciences Pvt. LtdUttar Pradesh | The sample does not comply as per I.P. 2022 with respect to the test for Dissolution of Metronidazole.Dissolution | RDTL,GuwahatiCDSCO lab |
| Methylcobalamin, Alpha Lipoic Acid, Pyridoxine Hydrochloride & Folic Acid Soft Gelatin Capsules) | BSG251184AMfg 2025-08 · Exp 2027-07 | Bionexy PharmaHimachal Pradesh | Test for Disintegration? and ?Assay for Methylcobalamin, Alpha Lipoic Acid Pyridoxine HydrochlorideAssay | RDTL, Bellary, KarnatakaState lab |
| Metformin Hydrochloride (SR) Tablets IP 1000mg, | JDT-7754Mfg 2024-02 · Exp 2026-01 | Jpee DrugsUttarakhand | DescriptionDescription | DTL, Bengaluru, KarnatakaState lab |
| Metformin Hydrochloride (ER) and Glimepiride Tablets IP | 244TGT008Mfg 2025-06 · Exp 2027-05 | Swiss Garnier Life SciencesHimachal Pradesh | Assay for GlimepirideAssay | RDTL, Bellary, KarnatakaState lab |
| Meropenem Injection IP | SDIC449BMfg 2025-09 · Exp 2027-08 | Sunvet HealthcareHimachal Pradesh | Tests for pH and Loss on dryingpH | DTL, Bengaluru, KarnatakaState lab |
| Meropenem Injection I.P. 125 mg | MPI2508Mfg 2025-08 · Exp 2027-07 | Modern LaboratoriesMadhya Pradesh | The sample does not conform to I.P. with respect to test for Clarity of solution, Particulate matter and Description.Description | CDL, KolkataCDSCO lab |
| Meropenem Injection I.P. 125 mg | MPI2504Mfg 2025-05 · Exp 2027-04 | Modern LaboratoriesMadhya Pradesh | The sample does not conform to I.P. with respect to test for Particulate matter, Clarity of solution, Assay of Meropenem calculated as Anhydrous Meropenem and Description.Assay | CDL, KolkataCDSCO lab |
| Meropenem Injection I.P. 125 mg | MPI2506Mfg 2025-07 · Exp 2027-06 | Modern LaboratoriesMadhya Pradesh | The sample does not conform to I.P. with respect to test for Particulate matter, Clarity of solution and Assay of Meropenem calculated as Anhydrous MeropenemAssay | CDL, KolkataCDSCO lab |
| Mehandi Cone | A1-027Mfg 2025-10 · Exp 2026-09 | Velnik India LimitedRajasthan | The sample of cosmetics- (C) Does not conform to the claims made on the label as to the nature and quality of the cosmetic with respect to Lawsone content (Nil) and pH.pH | DTL JaipurState lab |
| Mecobalamin, Alpha Lipoic Acid, Vitamin B6, Folic Acid, Zinc Sulphate Monohydrate, Chromium Polynicotinate, Selenium Dioxide, Biotin And Inositol Tablets | LP 108Mfg 2025-09 · Exp 2027-02 | Linto PharmaceuticalsPuducherry | Failed Assay (for Alpha Lipoic Acid)Assay | DTL, PuducherryState lab |
| Luliconazole Lotion IP 1% w/v | SWNL24J03Mfg 2024-10 · Exp 2026-09 | National Laboratories (Unit-II)Himachal Pradesh | Assay for Luliconazole onlyAssay | RDTL, Hubli, KarnatakaState lab |
| Lornoxicam & Paracetamol Tablets | CT60058Mfg 2025-04 · Exp 2027-03 | Cosmas Pharmacls LtdHimachal Pradesh | Uniformity of WeightUniformity of weight/content | Drugs Testing Laboratory, Madurai-19State lab |
| Lorazepam Tablets IP 1mg, | 5071TNIMfg 2025-04 · Exp 2028-03 | Windlas Biotech Limited (Plant-2)Uttarakhand | The particular sample fails the tests Dissolution and Assay.Assay | RDTL ErnakulamState lab |
| Lorazepam Tablets I.P. 1 mg | OM-10584Mfg 2024-07 · Exp 2027-06 | D.D. Pharmaceuticals Pvt. LtdRajasthan | The sample does not conform to claim as per I.P. 2022 with respect to the test for Dissolution and Assay of Lorazepam.Assay | RDTL,GuwahatiCDSCO lab |
| Lignocaine and Adrenaline Injection IP | HILR25002Mfg 2025-01 · Exp 2026-12 | Health Biotech LtdHimachal Pradesh | The sample does not conform to IP with respect to test for Particulate matter,Assay of Adrenaline Bitartrate eq. to Adrenaline and Description.Assay | CDL, KolkataCDSCO lab |
| Levosalbutamol, Guaiphenesin & Ambroxol Hcl Syrup | UFL250378LMfg 2025-04 · Exp 2027-03 | Ultra Drugs Formulations Pvt LtdHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Levosalbutamol, Ambroxol Hydrochloride & guaiphenesin Oral Drops | BL24-249Mfg 2024-11 · Exp 2026-10 | Biocore PharmaceuticalsHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Levosalbutamol, Ambroxol Hydrochloride & Guaiphenesin Syrup | PLP-005Mfg 2024-10 · Exp 2026-09 | Finemax Formulation Pvt. Ltd | DescriptionDescription | DTL, Bengaluru, KarnatakaState lab |
| Levosalbutamol Sulphate, ambroxol Hydrochloride and Guaiphensis Syrup | KBS-105Mfg 2025-09 · Exp 2027-08 | Krebz Healthcare Pvt. LtdTamil Nadu | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Levosalbutamol Sulphate, Ambroxol Hydrochloride and Guaiphenesin Syrup | DL5F051Mfg 2025-06 · Exp 2027-05 | Dr.Patel Pharmaceuticals Pvt. LtdGujarat | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Levosalbutamol Sulphate, Ambroxol Hydrochloride And Guaiphenesin Syrup | ASL24318Mfg 2024-12 · Exp 2026-11 | AASSK Pharmaceuticals Pvt. LtdTamil Nadu | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Levosalbutamol Sulphate, Ambroxol Hydrochloride & Guaiphenesin Syrup | FHYAM015Mfg 2025-08 · Exp 2027-07 | Innova Captab LtdHimachal Pradesh | The sample does not conform to the claim with respect to Assay of Ambroxol Hydrochloride & Guaiphenesin.Assay | DTL JaipurState lab |
| Levocetirizine Dihydrochloride and Montelukast Sodium Syrup | AL-24002Mfg 2025-01 · Exp 2026-12 | Tridus RemediesBihar | The sample does not conform to claim with respect to Assay of Montelukast Sodium and Description.Assay | CDL, KolkataCDSCO lab |
| Levocetirizine DiHydrochloride, Montelukast | SRT-034Mfg 2024-02 · Exp 2026-01 | Sresan Pharmaceutical ManufacturerKarnataka | DescriptionDescription | SDT&RL, BhubaneswarState lab |
| Itraconazole Capsules USP | GCF0298Mfg 2025-07 · Exp 2027-06 | Digital VisionHimachal Pradesh | The sample does not comply as per U.S.P. 2025 with respect to the test for Dissolution .Dissolution | RDTL,GuwahatiCDSCO lab |
| Iron and folic acid syrup IP | LAV25159ALMfg 2025-08 · Exp 2026-10 | Hindustan Laboratories LimitedMaharashtra | DescriptionDescription | Drugs Testing Laboratory, Madurai-19State lab |
| Iron Sucrose Injection USP 5 ml | 7505Mfg 2025-04 · Exp 2027-03 | Arco Lifesciences (India) Pvt Ltd C-86Maharashtra | sample Does not meet the Specifications w.r.t. Sterility Test.Sterility | DCL, TelanganaState lab |
| Iron Sucrose Injection USP 20mg/ml | VIN 24011Mfg 2024-02 · Exp 2026-01 | Infallible Pharma Pvt.Ltd | sample fails the tests 'Content of Chloride and pH as per USP, as specified in the Laboratory Protocol.pH | DTL ThiruvananthapuramState lab |
| Iron And Folic Acid Tablets I.P. | IFAT1245Mfg 2025-03 · Exp 2027-02 | Unicure India LtdUttar Pradesh | The sample does not conform to IP with respect to Description.Description | CDL, KolkataCDSCO lab |
| Iron & Folic Acid Tablets IP | IFS250104Mfg 2025-01 · Exp 2026-12 | Cipco PharmaceuticalsMadhya Pradesh | The sample is not of standard quality for the reason stated under Description.Description | RDTL,GuwahatiCDSCO lab |
| Iron & Folic Acid Syrup IP | 880525-BKN20Mfg 2025-05 · Exp 2027-04 | Biogenetic Drugs Pvt. LtdHimachal Pradesh | Test for pH and Assay for Elemental IronAssay | DTL, Bengaluru, KarnatakaState lab |
| Iron & Folic Acid Syrup IP | 1340625-BKN20Mfg 2025-06 · Exp 2027-05 | Biogenetic Drugs Pvt. LtdHimachal Pradesh | Test for DissolutionDissolution | DTL, Bengaluru, KarnatakaState lab |
| Ibuprofen Suspension 100mg/5ml | PL-022502Mfg 2025-02 · Exp 2027-01 | Primus PharmaceuticalsHimachal Pradesh | Test for pHpH | DTL, Bengaluru, KarnatakaState lab |
| Ibuprofen & Paracetamol Suspension | BPY24H09Mfg 2024-08 · Exp 2026-07 | Linux Life Sciences Pvt Ltd Plot No. 6 biotech park phase ? IIITelangana | Description and Assay of Ibuprofen and ParacetamolAssay | DCL, TelanganaState lab |
| IRON SUCROSE INJECTION USP | 7404Mfg 2024-04 · Exp 2026-03 | Arco Life Sciences India Pvt.Ltd C-86Maharashtra | sample Does not meet the Specifications w.r.t. Sterility Test.Sterility | DCL, TelanganaState lab |
| I.V. Cannula with Injection Port non return valve, wing Luer Lock | G220611060Mfg 2022-06 · Exp 2027-05 | Romsons Group Pvt. Ltd | The sample does not conform to Manufacturer specification with respect to the test for sterility.Sterility | CDL, KolkataCDSCO lab |
| I.V. Cannula with Injection Port and Wings | 3167422FMfg 2022-06 · Exp 2027-05 | Poly Medicure LtdHaryana | The sample does not conform to Manufacturer specification in respect to the Test of Flow rate, Sterility.Sterility | CDL, KolkataCDSCO lab |
| I.V. Cannula with Injection Port | 4006523AMfg 2023-01 · Exp 2027-12 | Poly Medicure LtdHaryana | The sample does not conform to Manufacturer specification in respect to the Test of Sterility and Flow rate.Sterility | CDL, KolkataCDSCO lab |
| Hydroxyzine Oral Solution I.P. | 25JL0872Mfg 2025-10 · Exp 2027-09 | Solar PharmaceuticalsPunjab | The sample does not conform to I.P. 2022 specification with respect to the test for pH only.pH | CDTL, HyderabadCDSCO lab |
| Hydrocortisone Sodium Succinate Injection IP | MD24H18Mfg 2024-08 · Exp 2026-01 | Martin & Brown Bio-Sciences Pvt. LtdHimachal Pradesh | The sample does not conform to I.P. with respect to test for pH, Clarity of Solution and Particulate MatterParticulate matter | CDL, KolkataCDSCO lab |
| Glycerin | G250719-IAMfg 2025-07 · Exp 2029-06 | Adani Wilmar LtdGujarat | The sample received does not conform tO I.P. 2022 specification with respect to refractive index, relative density, water content and Assay only.Assay | CDTL, HyderabadCDSCO lab |
| Folic Acid and Ferrous Sulphate Tablets (Large) N.F.I. | FFT3502Mfg 2025-08 · Exp 2027-07 | Modern LaboratoriesMadhya Pradesh | The sample does not conform to Standard Quality in respect of the test for Disintegration performedDisintegration | SDTL Govt. of Tripura, AgartalaState lab |
| Folic Acid and Ferrous Sulphate Tablets (Large) N.F.I. | FFT3501Mfg 2025-06 · Exp 2027-05 | Modern LaboratoriesMadhya Pradesh | The sample does not conform to Standard Quality in respect of the test for Disintegration performedDisintegration | SDTL Govt. of Tripura, AgartalaState lab |
| Flunarizine Tablets IP 10mg | AUJ01AQAMfg 2025-08 · Exp 2028-07 | Pure & Cure Healthcare Pvt.LtdUttarakhand | sample fails the test 'Descriptive Part' for tablets as per IP, as specified in the laboratory protocol.Other | DTL ThiruvananthapuramState lab |
| Ferrous Sulphate and Folic Acid Tablets IP | CFB-X25Mfg 2024-05 · Exp 2026-04 | Cyano Pharma (P) LtdMadhya Pradesh | The sample is not of standard quality for the reason stated under Description of the tablets.Description | RDTL,GuwahatiCDSCO lab |
| Enteric Coated Rabeprazole Sodium & Domperidone Sustained Release Capsule | SMC-1073Mfg 2024-07 · Exp 2026-06 | SMBJ Pharmaceuticals Pvt. LtdHaryana | content of Rabeprazole SodiumOther | Uttar PradeshState lab |
| Enrofloxacin & Bromhexine HCL Oral Solution (Quinrox-BH Antibacterial & Mucolytic For Veterinary Use) | QXB0525Mfg 2025-06 · Exp 2027-05 | Indovet Life Sciences Pvt. LtdTelangana | DescriptionDescription | RDTL, Bellary, KarnatakaState lab |
| Doxylamine Succinate Pyridoxine Hydrochloride & Folic acid Tablets | NPT25140AMfg 2025-06 · Exp 2027-05 | Nexkem Pharmaceuticals Pvt Ltd. IP-47Uttarakhand | The sample does not conform to claim as per patent & proprietary in respect to the Disintegration Test.Disintegration | DTL Baddi, Himachal PradeshState lab |
| Doxycycline & Lactic Acid Bacillus Tablets | T4514Mfg 2024-11 · Exp 2026-10 | Titanes Pharma | The sample does not conform to the claim with respect to Assay of Doxycycline & Description.Assay | DTL JaipurState lab |
| Diphenhydramine HCl, Ammonium Chloride, Sodium Citrate & Menthol Syrup | ZRSL - 1806Mfg 2025-09 · Exp 2027-08 | ZRS Pharmaceuticals India Pvt. LtdHimachal Pradesh | The sample does not conform to claim as per Patent and Proprietary in respect to the Assay of Sodium Citrate and Menthol.Assay | RDTL, ChandigarhCDSCO lab |
| Diclofenac Sodium Injection | 2507017Mfg 2025-03 · Exp 2027-02 | Neon Laboratories Ltd.at Plot No.G84/1 | Thesample does not conform to I.P w.r.t the test for Description and Particulate matterDescription | DTL, Dalgate Srinagar Kashmir ( J and K)State lab |
| Diclofenac Potassium & Chlorzoxazone Tablets | SMT-3395Mfg 2025-09 · Exp 2027-08 | SMBJ Pharmaceuticals Pvt Ltd. Plot No. 330Haryana | The sample nas been declared as Not of Standard Quality as it does not conform to IP Standards with respect Teet fhe to Test for DisintegrationDisintegration | KarnatakaState lab |
| Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride and Chlorpheniramine Maleate Syrup | SRLF250099Mfg 2025-06 · Exp 2027-05 | Systole Remedies Pvt LtdHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride and Chlorpheniramine Maleate Syrup | ML25245Mfg 2025-08 · Exp 2027-07 | Medimark Drugs & PharmaceuticalsUttarakhand | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride & Cetirizine Hydrochloride Syrup | L-25154Mfg 2025-09 · Exp 2027-08 | Apco Pharma LtdUttarakhand | The sample does not conform to Manufacturers specification with respect to test for Assay of Phenylephrine Hydrochloride.Assay | CDTL, MumbaiCDSCO lab |
| Dextromethorphan Hydrobromide, Cetirizine Dihydrochloride, Zinc and Ammonium Chloride Syrup | LC-2505Mfg 2025-06 · Exp 2027-05 | Frontline Pharmaceuticals Pvt. LtdMaharashtra | The sample received does not conform to I.P. 2022 with respect to the test for Assay for Cetrizine Dihydrochloride.Assay | CDTL, MumbaiCDSCO lab |
| Dextromethorphan Hbr, Phenylephrine Hcl, Chlorpheniramine Maleate Syrup | OML25074Mfg 2025-07 · Exp 2027-06 | Omish Laboratories Pvt. LtdGujarat | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Dextromethorphan HBr, Phenylephrine HCl & Chlorpheniramine Maleate Syrup | SVL-25199Mfg 2025-09 · Exp 2027-08 | Siddhi Vinayak IndustriesHimachal Pradesh | The sample does not conform to claim as per Patent and Proprietary in respect to the Assay of Phenylephrine Hydrochloride.Assay | RDTL, ChandigarhCDSCO lab |
| Dextromethorphan HBr, Phenylephrine HCL with Chlorpheniramine maleate Syrup | SP251109Mfg 2025-10 · Exp 2027-09 | Seejar Pharmaceuticals | The sample received does not conform to the claim with respect to the test for Assay of Dextromethorphan Hydrobromide and Phenylephrine Hydrochloride.Assay | CDTL, MumbaiCDSCO lab |
| Dextromethorphan HBR, Phenylephrine Hcl & Chlorpheniramine Maleate Syrup | ALD1185Mfg 2025-05 · Exp 2027-04 | Alzey Pharmaceuticals Pvt. LtdHaryana | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Dexamethasone Tablets IP 0.5mg | TA24659Mfg 2024-08 · Exp 2026-07 | Saintlife Pharmaceuticals LtdUttarakhand | Dissolution & ContentDissolution | Drugs Testing Laboratory, Chennai-06State lab |
| Defidrot Suspension | L058711-24Mfg 2024-11 · Exp 2026-10 | Adsila organics Pvt Ltd. Liwaspur road | The sample does not conforms to claim as per patent & Proprietary in respect to the Assay of Drotaverine Hydrochloride.Assay | DTL Baddi, Himachal PradeshState lab |
| Cyproheptadine Hydrochloride & Tricholine Citrate Syrup | HNG-25004Mfg 2025-05 · Exp 2027-04 | Tridus RemediesBihar | The sample does not conform to claim as per In house in respect to the Test of Ethylene glycol and Assay of Tricholine CitrateAssay | CDL, KolkataCDSCO lab |
| Cyproheptadine & Tricholine Citrate Oral Drugs 30 ml | 124Mfg 2025-09 · Exp 2027-08 | Luxica Pharma IncGujarat | The sample received does not conform to manufacturer's specification 2022 with respect to the test for pH.pH | CDTL, MumbaiCDSCO lab |
| Co-Trimoxazole Oral Suspension IP | CL250256AMfg 2025-09 · Exp 2027-08 | Candour PharmaceuticalsHimachal Pradesh | The sample does not conform to claim as per IP 2022 and Addendum 2024 in respect to the Test of Total microbial count, Total yeast and mould countMicrobial limits | RDTL, ChandigarhCDSCO lab |
| Co-Trimoxazole Oral Suspension IP | CL250267AMfg 2025-09 · Exp 2027-08 | Candour PharmaceuticalsHimachal Pradesh | The sample does not conform to claim as per IP 2022 and Addendum 2024 in respect to the Test of Total microbial count, Total yeast and mould countMicrobial limits | RDTL, ChandigarhCDSCO lab |
| Clopidogrel Tablets IP 75 mg | T-2405315Mfg 2024-05 · Exp 2026-04 | Rivpra Formulation Pvt. LtdUttarakhand | The sample received does not conform to IP 2022 specification with respect to the Description only.Description | CDTL, HyderabadCDSCO lab |
| Clopidogrel Tablets IP | BCGT25042Mfg 2025-07 · Exp 2027-06 | Bactolac Formulations Pvt. LtdTelangana | DescriptionDescription | Drugs Testing Laboratory, Chennai-06State lab |
| Clopidogrel Tablets IP | BCGT25048Mfg 2025-07 · Exp 2027-06 | Bactolac Formulations Pvt. LtdTelangana | DescriptionDescription | Drugs Testing Laboratory, Chennai-06State lab |
| Clopidogrel Tablets IP | BCGT25049Mfg 2025-07 · Exp 2027-06 | Bactolac Formulations Pvt. LtdTelangana | DescriptionDescription | Drugs Testing Laboratory, Chennai-06State lab |
| Clobetasol Propionate, Neomycin, Miconazole Nitrate & Chlorhexidine Cream | DLPS5027Mfg 2025-07 · Exp 2027-06 | Leeford Healthcare LtdHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Clobetasol Propionate, Neomycin, Miconazole Nitrate & Chlorhexidine Cream | DLPS5033Mfg 2025-07 · Exp 2027-06 | Leeford Healthcare LtdHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Clobetasol Propionate, Neomycin, Miconazole Nitrate & Chlorhexidine Cream | DLPS5019Mfg 2025-07 · Exp 2027-06 | Leeford Healthcare LtdHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Ciprofloxacin Tablets I.P 500mg | CCT1303Mfg 2025-04 · Exp 2027-03 | Unicure India LtdUttar Pradesh | Test for Uniformity of WeightUniformity of weight/content | RDTL, Hubli, KarnatakaState lab |
| Ciprofloxacin Tablets 500mg | SB2512Mfg 2025-10 · Exp 2029-09 | Sharika Biotech Jagat KhanaHimachal Pradesh | Assay of ciprofloxacinAssay | DTL Baddi, Himachal PradeshState lab |
| Cetirizine Dihydrochloride Tablets IP 10 mg | CTT-2416Mfg 2024-10 · Exp 2027-01 | Suprex laboratories 11/CMadhya Pradesh | DescriptionDescription | DCL, TelanganaState lab |
| Cetirizine Chydrochloride Syrup IP | MGMP 0898Mfg 2025-11 · Exp 2027-04 | Thorab Pharma and Research LaboratoryPuducherry | Failed pHpH | DTL, PuducherryState lab |
| Cefotaxime Sodium Injection IP 1000 mg | CT42414Mfg 2024-07 · Exp 2026-06 | Nandani Medical Laboratories Pvt. LtdMadhya Pradesh | The sample does not conform to I.P. with respect to test for Clarity of solution and Particulate matter.Particulate matter | CDL, KolkataCDSCO lab |
| Cefodoxime Proxetil & Ofloxacin Tablet | SKTC25002Mfg 2025-09 · Exp 2027-08 | Sharika Biotech Jagat KhanaHimachal Pradesh | Assay of ofloxacinAssay | DTL Baddi, Himachal PradeshState lab |
| Cefixime, Azithromycin & Lactic Acid Bacillus Tablets | CHO-50003Mfg 2025-01 · Exp 2026-12 | Park PharmaceuticalsHaryana | Assay for Cefixime (as Anhydrous) & Azithromycin (as Anhydrous) onlyAssay | RDTL, Hubli, KarnatakaState lab |
| Cefixime Dispersible Tablets IP | DTBE13AMfg 2025-05 · Exp 2027-04 | Digital VisionHimachal Pradesh | Test for Dissolution and Assay for CefiximeAssay | RDTL, Bellary, KarnatakaState lab |
| Cefixime & Ofloxacin Tablets | MBT-24775Mfg 2025-09 · Exp 2027-08 | Mayoford PharmaHimachal Pradesh | The sample does not conform to the claim with respect to Assay of Anhydrous Cefixime.Assay | DTL JaipurState lab |
| Calcium, Calcitriol & Vitamin K27 Softgel Capsules | D251340CMfg 2025-06 · Exp 2027-05 | Sigma Softgel & FormulationHimachal Pradesh | Test for DisintegrationDisintegration | RDTL, Bellary, KarnatakaState lab |
| Calcium with Vitamin D3 Suspension | JDL-3549Mfg 2024-12 · Exp 2026-11 | JPEE DrugsUttarakhand | The sample does not conform to the claim with respect to Assay of Vitamin D3.Assay | DTL JaipurState lab |
| Calcium with Vitamin D3 Suspension | JDL-3543Mfg 2024-12 · Exp 2026-11 | JPEE DrugsUttarakhand | The sample does not conform to the claim with respect to Assay of Vitamin D3.Assay | DTL JaipurState lab |
| Calcium Levulinate, Cholecalciferol & Cyanocobalmin Injetion Vet | JIN25-028Mfg 2025-05 · Exp 2027-04 | Janya Biocare Pvt. LtdUttarakhand | The sample does not conform to the IP with respect to Assay of Cholecalciferol.Assay | DTL JaipurState lab |
| Calcium Gluconate Injection I.P. | MA25E26Mfg 2025-05 · Exp 2026-10 | Martin & Brown Bio-Sciences Pvt.Ltd.. K. No. 918/419Himachal Pradesh | The sample fails in the Test for SterilitySterility | MDTL Kathua, Jammu and KashmirState lab |
| Calcium Carbonate, Vitamin D3, Magnesium & Zinc Sulphate Tablets | LTA-45710Mfg 2024-11 · Exp 2026-04 | Lifevision HealthcareHimachal Pradesh | The sample does not conform to claim as per Manufacturer's Specification with respect to the Assay of Zinc Sulphate Monohydrate equivalent to elemental Zinc.Assay | CDL, KolkataCDSCO lab |
| Calcium Carbonate Vitamin D3, Magnesium & Zinc Sulphate Tablets | LTA-47700Mfg 2025-04 · Exp 2026-09 | Lifevision HealthcareHimachal Pradesh | The sample does not conform to the claim with respect to Assay of Vitamin D3 and Elemental Zinc.Assay | DTL JaipurState lab |
| Calcium Carbonate & Vitamin D3 Tablets IP | GT17894CMfg 2025-02 · Exp 2027-01 | J. M. LaboratoriesHimachal Pradesh | The sample does not conform to claim as per IP 2022 in respect to the Test of Uniformity of content of Vitamin D3Uniformity of weight/content | RDTL, ChandigarhCDSCO lab |
| Calcium Carbonate & Vitamin D3 (Cholecalciferol) Tablets IP | NLT-43425Mfg 2025-07 · Exp 2027-06 | Nutra Life Healthcare Pvt. LtdUttarakhand | Assay for Vitamin D3Assay | DTL, Bengaluru, KarnatakaState lab |
| Calcium And Vitamin D3 Tablets IP | 45392Mfg 2024-10 · Exp 2026-09 | Healthy Life Pharma Pvt. Ltd. Factory : N ? 31/1Maharashtra | The sample fails in the Test for Description and Uniformity of weight of Tablets.Description | MDTL Kathua, Jammu and KashmirState lab |
| Buprenorphine Injection IP 2ml | 1364 ASOMfg 2025-06 · Exp 2028-05 | SNG Pharmaceuticals(P) LtdGujarat | The sample does not conform to IP with respect to test for Sterility, Related Substances, Particulate matter, Assay of Buprenorphine Hydrochloride and Description.Assay | CDL, KolkataCDSCO lab |
| Buprenorphine Injection IP 2ml | 1364 ASOMfg 2024-05 · Exp 2026-04 | SNG Pharmaceuticals(P) Ltd | The sample does not conform to IP with respect to test for pH, Related Substance, Particulate matter and Assay of Buprenorphine Hydrochloride.Assay | CDL, KolkataCDSCO lab |
| Buprenorphine Injection IP 2ml | BUP325004Mfg 2025-04 · Exp 2027-03 | Indus Pharma Pvt.LtdRajasthan | The sample does not conform to I.P. with respect to the Tests of Extractable volume, Particulate matter and for the reason stated under Description.Description | CDL, KolkataCDSCO lab |
| Buprenorphine Injection IP 2ml | BUP325004Mfg 2025-04 · Exp 2027-03 | Indus Pharma Pvt. LtdRajasthan | The sample does not conform I.P. with respect to the Test of Particulate matter and for the reason stated under Description.Description | CDL, KolkataCDSCO lab |
| Buprenorphine Injection IP 2ml | BUP325005Mfg 2025-05 · Exp 2027-04 | Indus Pharma Pvt.LtdRajasthan | The sample does not conform to I.P. with respect to the Tests of Particulate matter, Extractable volume and Description.Description | CDL, KolkataCDSCO lab |
| Bupivacaine Hydrochloride in Dextrose Injection USP | BD24D2Mfg 2024-12 · Exp 2026-11 | Arco Lifesciences (I) Pvt. LtdMaharashtra | The sample does not conform to U.S.P. with respect to test for Visible Particulates In Injection and Description.Description | CDL, KolkataCDSCO lab |
| Bromhexine Hydrochloride, Terbutaline Sulphate & Guaiphenesin & Menthol Syrup | EL24113Mfg 2024-02 · Exp 2026-01 | Edkem Pharmaceuticals Ltd.M9-M12. GallopsGujarat | The sample does not conform to claim as per Schedule V, Drugs & Cosmetics Act in respect to the Assay of MentholAssay | CDL, KolkataCDSCO lab |
| Bromhexine Hydrochloride Syrup-4mg/5ml | BHS24002Mfg 2024-03 · Exp 2027-02 | Galpha Laboratories LtdHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Bromhexine Hydrochloride,Terbutaline Sulphate,Guaiphenesin & Menthol Syrup | R12GL2424Mfg 2024-12 · Exp 2026-11 | Rednex Pharmaceuticals Pvt. LtdKerala | The sample does not conform to claim as per Schedule V, Drugs & Cosmetics Act in respect to the Assay of MentholAssay | CDL, KolkataCDSCO lab |
| Bromhexine Hydrochloride,Terbutaline Sulphate,Guaiphenesin & Menthol Syrup | R01GL2522Mfg 2025-01 · Exp 2026-12 | Rednex Pharmaceuticals Pvt.LtdKerala | The sample does not conform to claim as per Manufacturer method & specification in respect to the Assay of MentholAssay | CDL, KolkataCDSCO lab |
| Benzalkonium Chloride Disinfectant Fluid | MSSK01Mfg 2025-11 · Exp 2027-10 | Surfactants and Allied Chemicals (P) LtdTamil Nadu | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Bacillus clausii spores suspension | Z24-450Mfg 2024-06 · Exp 2026-05 | Zee Laboratories LtdHimachal Pradesh | The sample received does not conform toclaim with respect to Assay of Bacillus Clausii and Description.Assay | CDTL, MumbaiCDSCO lab |
| Atorvastatin Calcium Tablets IP 10mg | HTN792GMfg 2024-07 · Exp 2026-06 | Himalaya Meditek Pvt. LtdUttarakhand | DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab |
| Amoxycillin Dispersible Tablets IP | T-250554Mfg 2025-05 · Exp 2027-04 | Moon Marks Pharmaceuticals | The sample does not conforms to the I.P. with respect to Assay.Assay | DTLBikanerState lab |
| Amoxycillin & Potassium Clavulanate Tablets IP | TB24-0672DMfg 2024-10 · Exp 2026-09 | Athens Life Sciences Mauza Rampur JattanHimachal Pradesh | Assay of Amoxycillin and Clavulanic acid and Dissolution test for AmoxycillinAssay | DCL, TelanganaState lab |
| Amoxycillin & Potassium Clavulanate Tablets IP | MYRTAB-1038Mfg 2025-04 · Exp 2026-09 | Mayer Lab ChambaghatHimachal Pradesh | Assay and Dissolution of Clavulanic Acid does not comply as per IP. 2022Assay | DCL, TelanganaState lab |
| Amoxicillin And Potassium Clavulanate TabletsIP 625 mg | APCT25014AMfg 2025-02 · Exp 2026-07 | Karnataka Antibiotics & Pharmaceuticals LtdKarnataka | The sample does not conform to IP with respect to the test of Dissolution Of Potassium Clavulanate and Assay of Potassium Clavulanate.Assay | CDTL, IndoreCDSCO lab |
| Amlodipine Tablets I.P. 2.5 mg | 424-1521Mfg 2024-08 · Exp 2026-07 | Zee LaboratoriesHimachal Pradesh | The sample is not of standard quality for the reason stated under Description of the tabletsDescription | RDTL,GuwahatiCDSCO lab |
| Amlodipine & Atenolol Tablets IP | TH-130010Mfg 2024-11 · Exp 2027-10 | Centurion Remedies Pvt. LtdGujarat | The sample does not conform to the I.P. with respect to Assay of Amlodipine.Assay | DTL JaipurState lab |
| Amitriptyline Tablets IP | DRT24032Mfg 2024-02 · Exp 2026-01 | Eastern HealthcareUttarakhand | The sample does not conform to I.P. in respect of the test Assay performed.Assay | West BengalState lab |
| Ambroxol, Terbutaline, Guaiphenesin & Menthol Syrup | BRAS-065Mfg 2025-05 · Exp 2027-10 | IOSIS Remedies Pvt LtdHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Ambroxol Hydrochloride, Terbutaline Sulphate, Guaiphenesin With Menthol Syrup | TL2509013Mfg 2025-09 · Exp 2027-08 | Tychos Therapeutics Pvt. LtdTamil Nadu | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Ambroxol Hydrochloride, Terbutaline Sulphate, Guaiphenesin And Menthol Syrup | MZYA02Mfg 2025-01 · Exp 2026-12 | Zeta Formulation Pvt. Ltd | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Ambroxol Hydrochloride, Terbutaline Sulphate, Guaiphenesin & Menthol Syrup | NB10L017AMfg 2025-10 · Exp 2027-09 | NDB HealthcareHimachal Pradesh | The sample does not conform to claim as per Patent and Proprietary in respect to the Assay of MentholAssay | RDTL, ChandigarhCDSCO lab |
| Ambroxol Hydrochloride, Terbutaline Sulphate, Guaiphenesin & Menthol Syrup | DLS3877Mfg 2025-01 · Exp 2026-12 | Dhwanilife Care Pvt. LtdGujarat | The sample does not conform to the claim with respect in Assay of Ambroxol Hydrochloride.Assay | DTL JaipurState lab |
| Ambroxol Hydrochloride, Terbutaline Sulphate and Guaiphenesin Syrup & Menthol Syrup | MDL-B458Mfg 2024-09 · Exp 2026-08 | Marvellon Pharmaceuticals Pvt. LtdHimachal Pradesh | The sample does not conform to the claim with respect to In Assay Terbutaline Sulphate, Ambroxol Hydrochloride and Guaiphenesin.Assay | DTL JaipurState lab |
| Ambroxol Hydrochloride, Terbutaline Sulphate and Guaiphenesin Syrup | AT18S125Mfg 2025-09 · Exp 2027-08 | CIPCO LimitedMadhya Pradesh | The sample does not conform to the claim with respect to In Assay of Ambroxol Hydrochloride.Assay | DTL JaipurState lab |
| Ambroxol Hydrochloride, Terbutaline Sulphate and Guaiphenesin Syrup | AT22A225Mfg 2025-08 · Exp 2027-07 | CIPCO LimitedMadhya Pradesh | The sample does not conform to the claim with respect to Assay of Ambroxol Hydrochloride.Assay | DTL JaipurState lab |
| Ambroxol Hydrochloride, Terbutaline Sulphate and Guaiphenesin Syrup | AT13A225Mfg 2025-08 · Exp 2027-07 | CIPCO LimitedMadhya Pradesh | The sample does not conform to the claim with respect to Assay of Ambroxol Hydrochloride.Assay | DTL JaipurState lab |
| Ambroxol Hydrochloride, Terbutaline Sulphate and Guaiphenesin Syrup | AT48J325Mfg 2025-07 · Exp 2027-06 | CIPCO LimitedMadhya Pradesh | The sample does not conform to the claim with respect to Assay of Ambroxol Hydrochloride.Assay | DTL JaipurState lab |
| Ambroxol Hydrochloride, Terbutaline Sulphate and Guaiphenesin Syrup | AT11S125Mfg 2025-09 · Exp 2027-08 | CIPCO LimitedMadhya Pradesh | The sample does not conform to the claim with respect to Assay of Ambroxol Hydrochloride.Assay | DTL JaipurState lab |
| Ambroxol Hydrochloride, Levosalbutamol Sulphate & Guaiphenesin Syrup | ULL25042Mfg 2025-04 · Exp 2027-03 | Ultatech PharmaceuticaqlsHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Ambroxol Hydrochloride, Guaiphenesin, Levosalbutamol Sulphate Syrup | A-250613Mfg 2025-06 · Exp 2027-05 | Onex Pharmaceuticals | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Ambroxol Hydrochloride, Guaiphenesin and Levosalbutamol Sulphate Syrup | FL250085Mfg 2025-10 · Exp 2027-09 | Farma Hub Overseas Pvt. Ltd (FHO)Uttarakhand | The sample does not conform to Manufacturers Specification with respect to test for Assay of Ambroxol HydrochlorideAssay | CDTL, MumbaiCDSCO lab |
| Ambroxol Hydrochloride, Guaiphenesin & Terbutaline Sulphate Syrup | L2502010Mfg 2025-02 · Exp 2027-01 | Rivpra Formulations Pvt. LtdUttarakhand | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Ambroxol Hydrochloride, Guaiphenesin & Terbutaline Sulphate Syrup | L2502007Mfg 2025-02 · Exp 2027-01 | Rivpra Formulations Pvt. LtdUttarakhand | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Ambroxol Hydrochloride, Guaiphenesin & Levosalbutamol Sulphate Syrup | SBL-8Mfg 2025-04 · Exp 2027-03 | Sarthak Biotech Pvt. Ltd | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Ambroxol Hydrochloride, I.P-15.0mg Terbutaline Sulphate, I.P-1.25mg Guaiphenesin, I.P- 50.0mg Menthol, I.P -2.5mg | MCPD-189Mfg 2025-07 · Exp 2027-06 | Mothers Care Pharma Labs Pvt.LtdOdisha | The sample does not conform to claim with respect to Aassay of MentholAssay | CDL, KolkataCDSCO lab |
| Ambroxol Hydrochloride, I.P-15.0mg Salubutamol Sulphate Equivalent to Salbutamol, I.P-1mg Guaiphenesin, I.P- 50.0mg Menthol, I.P -1mg Sorbitol base -q.s. Colour: Sunset Yellow FCF | AS036-25Mfg 2025-01 · Exp 2026-12 | Harihar Pharmaceuticals Pvt.LtdOdisha | The sample does not conform to claim with respect to Assay of Menthol.Assay | CDL, KolkataCDSCO lab |
| Ambroxol Hcl, Dextromethorphan Hbr, Phenylephrine Hcl, Chlorpheniramine Maleate & Menthol Syrup | RPL863Mfg 2025-05 · Exp 2027-04 | Rumy PharmaceuticalsHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Ambroxol HCl, Terbutaline Sulphate, Guaiphenesin & Methol Syrup | SVL-25194Mfg 2025-09 · Exp 2027-08 | Siddhi Vinayak IndustriesHimachal Pradesh | The sample does not conform to claim as per Patent and Proprietary in respect to the Assay of Terbutaline SulphateAssay | RDTL, ChandigarhCDSCO lab |
| Aluminium Hydroxide, Magnesium Hydroxide & Simethicone Oral Suspension IP | PL-40143Mfg 2024-06 · Exp 2026-05 | Pharmaroots Healthcare. Khasra No.411Himachal Pradesh | Content and Microbial LimitMicrobial limits | Drugs Testing Laboratory, Chennai-06State lab |
| Albendazole Tablets IP 400 mg | 0112Mfg 2025-01 · Exp 2026-12 | Hindustan Antibiotics LtdMaharashtra | The sample does not conform to I.P. with respect to test for Dissolution.Dissolution | CDL, KolkataCDSCO lab |
| Albendazole Tablets IP 400 mg | APR-00Mfg 2025-01 · Exp 2026-12 | Hindustan Antibiotics LtdMaharashtra | The sample does not conform to I.P. with respect to test for Dissolution.Dissolution | SDT&RL, BhubaneswarState lab |
| Acetyl Cysteine Injection BP | 529Mfg 2025-10 · Exp 2027-09 | Carewin Pharmaceuticals (GUJ) Pvt. LtdGujarat | The sample does not conform to B.P. with respect to the test for Sterility.Sterility | CDL, KolkataCDSCO lab |
| Aceclofenac, Paracetamol & Serratiopeptidase Tablets | APSP-45Mfg 2025-04 · Exp 2027-03 | Franklin Laboratories (India) Pvt. LtdUttarakhand | DescriptionDescription | RDTL, Bellary, KarnatakaState lab |
| Aceclofenac, Paracetamol & Serratiopeptidase Tablets | MDT-4458Mfg 2025-09 · Exp 2027-08 | Mayasha LifesciencesHimachal Pradesh | The sample does not conform to the claim with respect to Assay of Aceclofenac.Assay | DTL JaipurState lab |
| Aceclofenac, Paracetamol & Chlorzoxazone Tablets | VGT/2201Mfg 2024-04 · Exp 2026-03 | Vats Biotech Pvt. LtdHimachal Pradesh | Description and Assay for AceclofenacAssay | RDTL, Bellary, KarnatakaState lab |
| Aceclofenac & paracetamol tablets | ACAUT-007Mfg 2025-07 · Exp 2028-06 | Laborate pharmaceuticals India ltd. 51Himachal Pradesh | MisbrandedMisbranded | DCL, TelanganaState lab |
| Aceclofenac & Paracetamol Tablets | T250216Mfg 2025-02 · Exp 2027-01 | Medisky PharmaceuticalsGujarat | The sample does not conform to Addendum 2024 of I.P 2022 with respect to the Assay of Aceclofenac.Assay | CDTL, IndoreCDSCO lab |
| Acebrophylline and Acetylcysteine tablets | SB-9620Mfg 2025-01 · Exp 2026-12 | San-cito Therapeutics Inc Vill. LoharanHimachal Pradesh | DescriptionDescription | DCL, TelanganaState lab |
Suspected spurious batches in this alert
| Product | Batch | Labelled manufacturer | Reported by | Firm's reply |
|---|---|---|---|---|
| Trypsin-Chymotrypsin Tablets | 2KU6L055 | Torrent Pharmaceuticals Ltd. 32 No. Middle Camp NH-10 East District Gangtok, Sikkim 737135 | FDAL Maharashtra | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. |
| Azithromycin USP/EP/IP | 129-250324-1 | Under Investigation | CDTL, Mumbai | The actual importer (as per label claim) has informed that the impugned batch of the product has not supplied by them and that it is a spurious drug. |
| Ofloxacin And Ornidazole Tablets IP | E-50032 | Under Investigation | West Bengal | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. |
| Trypsin-Chymotrypsin Tablets | 2KU6L050 | Under Investigation | CDL, Kolkata | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. |
Check your medicine. Enter the batch number printed on the strip, bottle or carton to see whether it appears in this or any earlier alert. Check a batch number
Official sources and primary records
- Regulator
- Regulator
Changelog
- 20 Sep 2026: table generated from the CDSCO NSQ portal export (218 rows). Revised CDSCO lists are diffed on each monthly rebuild.